AMAG Pharmaceuticals falls short

AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) fell to a greater than expected loss for the first quarter of 22 cents per diluted share compared with earnings of 39 cents per diluted share in the year ago period. The stock price plunged $3.65 to close at $22.03.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.